Human metapneumovirus G protein is highly conserved within but not between genetic lineages

Archives of Virology

Volumn 158, Issue 6, 2013, Pages 1245-1252

  Yang, Chin Fen ^b   Wang, Chiaoyin K ^b   Tollefson, Sharon J ^a   Lintao, Linda D ^b   Liem, Alexis ^b   Chu, Marla ^b   Williams, John V ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G GLYCOPROTEIN, HUMAN METAPNEUMOVIRUS; GLYCOPROTEIN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; GENETIC VARIABILITY; GENETICS; HUMAN; METAPNEUMOVIRUS; NUCLEOTIDE SEQUENCE; PARAMYXOVIRUS INFECTION; PHYLOGENY; PHYSIOLOGY; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; VIROLOGY;

AMINO ACID SEQUENCE; BASE SEQUENCE; CHILD, PRESCHOOL; CONSERVED SEQUENCE; GENETIC VARIATION; GLYCOPROTEINS; HUMANS; METAPNEUMOVIRUS; PARAMYXOVIRIDAE INFECTIONS; PHYLOGENY; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; VIRAL PROTEINS;

HUMAN METAPNEUMOVIRUS;

EID: 84878597497     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-013-1622-x     Document Type: Article

References (55)

1. van den Hoogen BG et al (2001) A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7(6): 719-724.
2. Boivin G et al (2007) An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility. Clin Infect Dis 44(9): 1152-1158.
3. Dollner H et al (2004) Outbreak of human metapneumovirus infection in norwegian children. Pediatr Infect Dis J 23(5): 436-440.
4. Ebihara T et al (2004) Human metapneumovirus infection in Japanese children. J Clin Microbiol 42(1): 126-132.
5. Esper F et al (2004) A 1-year experience with human metapneumovirus in children aged < 5 years. J Infect Dis 189(8): 1388-1396.
6. Gray GC et al (2006) Multi-year study of human metapneumovirus infection at a large US Midwestern Medical Referral Center. J Clin Virol 37(4): 269-276.
7. Hamelin ME et al (2005) Human metapneumovirus infection in adults with community-acquired pneumonia and exacerbation of chronic obstructive pulmonary disease. Clin Infect Dis 41(4): 498-502.
8. Kahn JS (2006) Epidemiology of human metapneumovirus. Clin Microbiol Rev 19(3): 546-557.
9. Madhi SA et al (2007) Seasonality, incidence, and repeat human metapneumovirus lower respiratory tract infections in an area with a high prevalence of human immunodeficiency virus type-1 infection. Pediatr Infect Dis J 26(8): 693-699.
10. Maggi F et al (2003) Human metapneumovirus associated with respiratory tract infections in a 3-year study of nasal swabs from infants in Italy. J Clin Microbiol 41(7): 2987-2991.
11. Martinello RA et al (2006) Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease. J Infect 53(4): 248-254.
12. van den Hoogen BG, Osterhaus DM, Fouchier RA (2004) Clinical impact and diagnosis of human metapneumovirus infection. Pediatr Infect Dis J 23(1 Suppl): S25-S32.
13. Williams JV et al (2010) Population-based incidence of human metapneumovirus infection among hospitalized children. J Infect Dis 201(12): 1890-1898.
14. Williams JV et al (2004) Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 350(5): 443-450.
15. Williams JV et al (2006) The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. J Infect Dis 193(3): 387-395.
16. Buys SB, du Preez JH, Els HJ (1989) The isolation and attenuation of a virus causing rhinotracheitis in turkeys in South Africa. Onderstepoort J Vet Res 56(2): 87-98.
17. Njenga MK, Lwamba HM, Seal BS (2003) Metapneumoviruses in birds and humans. Virus Res 91(2): 163-169.
18. Toquin D et al (2003) Subgroup C avian metapneumovirus (MPV) and the recently isolated human MPV exhibit a common organization but have extensive sequence divergence in their putative SH and G genes. J Gen Virol 84(Pt 8): 2169-2178.
19. de Graaf M et al (2008) Evolutionary dynamics of human and avian metapneumoviruses. J Gen Virol 89(Pt 12): 2933-2942.
20. Yang CF et al (2009) Genetic diversity and evolution of human metapneumovirus fusion protein over twenty years. Virol J 6: 138.
21. Cseke G et al (2009) Integrin alphavbeta1 promotes infection by human metapneumovirus. Proc Natl Acad Sci U S A 106(5): 1566-1571.
22. de Graaf M et al (2009) Fusion protein is the main determinant of metapneumovirus host tropism. J Gen Virol 90(Pt 6): 1408-1416.
23. Miller SA et al (2007) Examination of a fusogenic hexameric core from human metapneumovirus and identification of a potent synthetic peptide inhibitor from the heptad repeat 1 region. J Virol 81(1): 141-149.
24. Schowalter RM, Smith SE, Dutch RE (2006) Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH. J Virol 80(22): 10931-10941.
25. Thammawat S et al (2008) Role of cellular glycosaminoglycans and charged regions of viral G protein in human metapneumovirus infection. J Virol 82(23): 11767-11774.
26. Biacchesi S et al (2004) Recombinant human Metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate. J Virol 78(23): 12877-12887.
27. Biacchesi S et al (2005) Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates. J Virol 79(19): 12608-12613.
28. Bao X et al (2008) Human metapneumovirus glycoprotein G inhibits innate immune responses. PLoS Pathog 4(5): e1000077.
29. Kolli D et al (2011) Human metapneumovirus glycoprotein G inhibits TLR4-dependent signaling in monocyte-derived dendritic cells. J Immunol 187(1): 47-54.
30. Kumar S, Tamura K, Nei M (2004) MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform 5(2): 150-163.
31. Drummond AJ, Rambaut A (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7: 214.
32. Hasegawa M, Kishino H, Yano T (1985) Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J Mol Evol 22(2): 160-174.
33. van den Hoogen BG et al (2004) Antigenic and genetic variability of human metapneumoviruses. Emerg Infect Dis 10(4): 658-666.
34. Johnson PR et al (1987) The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. Proc Natl Acad Sci U S A 84(16): 5625-5629.
35. Wertz GW et al (1985) Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein. Proc Natl Acad Sci U S A 82(12): 4075-4079.
36. Roberts SR et al (1994) The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons. J Virol 68(7): 4538-4546.
37. Trento A et al (2006) Natural history of human respiratory syncytial virus inferred from phylogenetic analysis of the attachment (G) glycoprotein with a 60-nucleotide duplication. J Virol 80(2): 975-984.
38. Martin DP et al (2010) RDP3: a flexible and fast computer program for analyzing recombination. Bioinformatics 26(19): 2462-2463.
39. Gaunt ER et al (2011) Molecular epidemiology and evolution of human respiratory syncytial virus and human metapneumovirus. PloS one 6(3): e17427.
40. Padhi A, Verghese B (2008) Positive natural selection in the evolution of human metapneumovirus attachment glycoprotein. Virus Res 131(2): 121-131.
41. Skiadopoulos MH et al (2006) Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity. Virology 345(2): 492-501.
42. Ryder AB et al (2010) Soluble recombinant human metapneumovirus G protein is immunogenic but not protective. Vaccine 28(25): 4145-4152.
43. Mok H et al (2008) An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats. J Virol 82(22): 11410-11418.
44. Endo R et al (2008) Detection of four genetic subgroup-specific antibodies to human metapneumovirus attachment (G) protein in human serum. J Gen Virol 89(Pt 8): 1970-1977.
45. Herd KA et al (2006) Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice. J Virol 80(4): 2034-2044.
46. Herd KA et al (2008) Major histocompatibility complex class I cytotoxic T lymphocyte immunity to human metapneumovirus (hMPV) in individuals with previous hMPV infection and respiratory disease. J Infect Dis 197(4): 584-592.
47. Erickson JJ et al (2012) Viral acute lower respiratory infections impair CD8 + T cells through PD-1. J Clin Invest 122(8): 2967-2982.
48. Liu L, Bastien N, Li Y (2007) Intracellular processing, glycosylation, and cell surface expression of human metapneumovirus attachment glycoprotein. J Virol 81(24): 13435-13443.
49. Wertheim JO, Worobey M (2009) Relaxed selection and the evolution of RNA virus mucin-like pathogenicity factors. J Virol 83(9): 4690-4694.
50. Schildgen V et al (2011) Human Metapneumovirus: lessons learned over the first decade. Clin Microbiol Rev 24(4): 734-754.
51. McCarthy AJ, Goodman SJ (2010) Reassessing conflicting evolutionary histories of the Paramyxoviridae and the origins of respiroviruses with Bayesian multigene phylogenies. Infect Genet Evol 10(1): 97-107.
52. Rambaut A et al (2008) The genomic and epidemiological dynamics of human influenza A virus. Nature 453(7195): 615-619.
53. van den Hoogen BG et al (2002) Analysis of the genomic sequence of a human metapneumovirus. Virology 295(1): 119-132.
54. Sharp PM, Simmonds P (2011) Evaluating the evidence for virus/host co-evolution. Curr Opin Virol 1(5): 436-441.
55. Velayudhan BT et al (2006) Human metapneumovirus in turkey poults. Emerg Infect Dis 12(12): 1853-1859.